POLYPEPTID FÜR ADOPTIVE ZELLTHERAPIE

European patent · EP2836511 · In force

Register entry

Publication number
EP2836511
Application number
EP13717833
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 11, 2013
Published
Feb 18, 2015
Granted
Nov 29, 2017
Protection ends at the latest
Apr 10, 2033
Next annual fee due
Apr 30, 2027
IPC classes
C07K 14/705 (2006.01)
C12N 15/62 (2006.01)
Priority
GB 201206559 13.04.2012
PCT application
PCT/GB2013/050935 11.04.2013
PCT publication
WO2013/153391 17.10.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Nov 29, 2017

    Granted

    Published in Swissreg on 29.11.2017

Parties

Holder

UCL Business PLC

The Network Building 97 Tottenham Court Road, London W1T 4TP, GB

Inventor

PULÉ, Martin

London WC1E 6BT, GB

PHILIP, Brian

London WC1E 6BT, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.